trending Market Intelligence /marketintelligence/en/news-insights/trending/ecgxKFE3b352722pv470bQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Biotechnology company Fiji Kava raises A$5.2M in ASX IPO

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Biotechnology company Fiji Kava raises A$5.2M in ASX IPO

Fiji Kava Ltd., a company developing therapeutics using the kava plant, raised A$5.2 million in its IPO on the Australia Securities Exchange.

The Subiaco, Australia-based company sold 26 million ordinary shares at 20 Australian cents per share in the offering.

Pac Partners Securities Pty Ltd. acted as lead manager for the offering.